<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - AZTREONAM</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>AZTREONAM</h1>


      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#drugAction" data-toggle="tab">Drug action</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#renalImpairment" data-toggle="tab">Renal impairment</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#directionsForAdministration" data-toggle="tab">Administration</a></li>
          <li><a href="#nationalFunding" data-toggle="tab">National funding/access decisions</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#monitoringRequirements" data-toggle="tab">Monitoring requirements</a></li>
          <li><a href="#allergyAndCrossSensitivity" data-toggle="tab">Allergy and cross sensitivity</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Gram-negative infections including <ph outputclass="organism"> <i>Pseudomonas aeruginosa</i> </ph>, <ph outputclass="organism"> <i>Haemophilus influenzae</i> </ph>, and <ph outputclass="organism"> <i>Neisseria meningitidis</i> </ph></span>,
            </h4>
            <p class="specificity"><span class="route">By deep intramuscular injection or by intravenous infusion or by intravenous injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                1 g every 8 hours, alternatively 2 g every 12 hours, single doses over 1 g intravenous route only.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Severe gram-negative infections including <ph outputclass="organism"> <i>Pseudomonas aeruginosa</i> </ph>, <ph outputclass="organism"> <i>Haemophilus influenzae</i> </ph>, <ph outputclass="organism"> <i>Neisseria meningitidis</i> </ph>, and lung infections in cystic fibrosis</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion or by intravenous injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                2 g every 6&#8211;8 hours.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Gonorrhoea</span>,
                <span class="indication">Cystitis</span>,
            </h4>
            <p class="specificity"><span class="route">By intramuscular injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                1 g for 1 single dose.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Urinary-tract infections</span>,
            </h4>
            <p class="specificity"><span class="route">By deep intramuscular injection or by intravenous infusion or by intravenous injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                0.5&#8211;1 g every 8&#8211;12 hours.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Chronic pulmonary <ph outputclass="organism"> <i>Pseudomonas aeruginosa</i> </ph> infection in patients with cystic fibrosis</span>,
            </h4>
            <p class="specificity"><span class="route">By inhalation of nebulised solution</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                75 mg 3 times a day for 28 days, doses to be administered at least 4 hours apart, subsequent courses repeated after 28-day interval without aztreonam nebuliser solution.</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
      </section>


      <section class="tab-pane" id="drugAction">
        <h2>Drug action</h2>

            <section class="drugAction">
              <p>Aztreonam is a monocyclic beta-lactam (&#8216;monobactam&#8217;) antibiotic with an antibacterial spectrum limited to Gram-negative aerobic bacteria including <ph outputclass="organism">
            <i>Pseudomonas aeruginosa</i>
            </ph>, <ph outputclass="organism">
            <i>Neisseria meningitidis</i>
            </ph>, and <ph outputclass="organism">
            <i>Haemophilus influenzae</i>
            </ph>; it should not be used alone for &#8216;blind&#8217; treatment since it is not active against Gram-positive organisms. Aztreonam is also effective against <ph outputclass="organism">
            <i>Neisseria gonorrhoeae</i>
            </ph> (but not against concurrent chlamydial infection).</p>
            </section>
      </section>

      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">systemic</ph> use</h3>
              <p>No information available; manufacturer of injection advises avoid.</p>
            </section>
            <section class="generalInformation">
              <h3 class="specificity">When used by <ph outputclass="route">inhalation</ph></h3>
              <p>No information available; manufacturer of powder for nebuliser solution advises avoid unless essential.</p>
            </section>
      </section>

      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">systemic</ph> use</h3>
              <p>Use injection with caution.</p>
            </section>
      </section>

      <section class="tab-pane" id="renalImpairment">
        <h2>Advice regarding renal impairment</h2>

            <section class="doseAdjustments">
              <h3 class="specificity">With <ph outputclass="route">systemic</ph> use</h3>
              <p>If eGFR 10&#8211;30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, usual initial dose of injection, then half normal dose.</p><p>If eGFR less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, usual initial dose of injection, then one-quarter normal dose.</p>
            </section>
        
      </section>


      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

          <h3>General side effects</h3>
              <p>
                <strong>notKnown:</strong> Bronchospasm, rash,
              </p>
        
          <h3>Specific side effects</h3>
              <p>
                <strong>rare:</strong> antibiotic-associated colitis, asthenia, blood disorders, breast tenderness, chest pain, confusion, diplopia, dizziness, dyspnoea, gastro-intestinal bleeding, halitosis, headache, hepatitis, hypotension, insomnia, jaundice, myalgia, neutropenia, paraesthesia, seizures, thrombocytopenia, tinnitus,
              </p>
              <p>
                <strong>notKnown:</strong> arthralgia, cough, haemoptysis, pharyngolaryngeal pain, pyrexia, rhinorrhoea, wheezing, abdominal pain, diarrhoea, erythema multiforme, flushing, mouth ulcers, nausea, taste disturbances, toxic epidermal necrolysis, vomiting,
              </p>
        
        
      </section>

      <section class="tab-pane" id="directionsForAdministration">
        <h2>Directions for administration</h2>

            <section class="directionsForAdministration">
              <p>For <i>intravenous injection</i>, give over 3&#8211;5 minutes.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use</h3>
              <p>For <i>intravenous infusion</i> (<i>Azactam<tm tmtype="reg"/>
            </i>), give intermittently <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%.</p><p>Dissolve initially in water for injections (1&#8239;g per 3&#8239;mL) then dilute to a concentration of less than 20&#8239;mg/mL; to be given over 20&#8211;60 minutes.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">When used by <ph outputclass="route">inhalation</ph></h3>
              <p>Other inhaled drugs should be administered before aztreonam; a bronchodilator should be administered before each dose.</p>
            </section>
      </section>


      <section class="tab-pane" id="nationalFunding">
        <h2>National funding/access decisions</h2>

      </section>


      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
              <strong>When used by inhalation:</strong>
            haemoptysis&#8212; risk of further haemorrhage
          </li>
        </ul>
      </section>


      <section class="tab-pane" id="monitoringRequirements">
        <h2>Monitoring requirements</h2>

        
          <h3>Patient parameters</h3>
        
            <section class="patientParameters">
              <h3 class="specificity">When used by <ph outputclass="route">inhalation</ph></h3>
              <p>Measure lung function before and after initial dose of aztreonam and monitor for bronchospasm.</p>
            </section>
      </section>










      <section class="tab-pane" id="allergyAndCrossSensitivity">
        <h2>Advice regarding allergies and cross sensitivities</h2>

            <section class="contraindications">
              <p>Contra-indicated in aztreonam hypersensitivity.</p>
            </section>
        
            <section class="crossSensitivity">
              <p>Use with caution in patients with hypersensitivity to other beta-lactam antibiotics (although aztreonam may be less likely than other beta-lactams to cause hypersensitivity in penicillin-sensitive patients).</p>
            </section>
      </section>

      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of AZTREONAM</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        

            <div id="PHP76021"><a href="../medicinalForm/PHP76021.html" data-target="#PHP76021" data-action="load">Powder for solution for injection</a></div>
            <div id="PHP76033"><a href="../medicinalForm/PHP76033.html" data-target="#PHP76033" data-action="load">Powder and solvent for nebuliser solution</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
